Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02607683 · ClinicalTrials.gov registry record · Phase 2
Phase 2b/3 Study of XAF5 Ointment for Steatoblepharon (Undereye Bags)
A Phase 2 study, sponsored by Topokine Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 300
- Enrollment target
NCT02607683: Completed Phase 2 study, sponsored by Topokine Therapeutics.
NCT02607683 is a Phase 2 study that has completed, run by Topokine Therapeutics. The registered enrollment target is 300 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (126% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02607683, a Phase 2 study, has completed, sponsored by Topokine Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 300 participants
- Enrollment target
Study Summary
This randomized, placebo-controlled, double-masked, Phase 2b/Phase 3 study will assess the efficacy of two different concentrations of XAF5 Ointment for reduction of lower lid steatoblepharon (undereye bags).
Interventions
- DRUG Matching placebo
- DRUG XAF5 (concentration A: 0.1%)
- DRUG XAF5 (concentration B: 0.035%)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2016-01-01 |
| Est. Completion | 2016-10-31 |
| Phase | Phase 2 |
What the finished NCT02607683 record still lists
NCT02607683 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (126% higher).
The record links to 0 conditions, and to 3 interventions - of which Matching placebo is the first listed.
NCT02607683 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02607683 about?
NCT02607683 is a clinical study titled "Phase 2b/3 Study of XAF5 Ointment for Steatoblepharon (Undereye Bags)". This randomized, placebo-controlled, double-masked, Phase 2b/Phase 3 study will assess the efficacy of two different concentrations of XAF5 Ointment for reduction of lower lid steatoblepharon (undereye bags).
What is the current status of trial NCT02607683?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 300 participants. The study started on 2016-01-01. Estimated completion is 2016-10-31.
What interventions are being tested in trial NCT02607683?
The interventions under investigation include: Matching placebo (DRUG), XAF5 (concentration A: 0.1%) (DRUG), XAF5 (concentration B: 0.035%) (DRUG).
Who is sponsoring clinical trial NCT02607683?
This trial is sponsored by Topokine Therapeutics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02607683's enrollment target sits among peer trials
300 167th of 2000 higher than 1,813 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI